Stem Cell Processing (Stem Cells in Clinical Applications)

(Michael S) #1

98


Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner
A et al (2010) Highly effi cient reprogramming to pluripotency and directed differentiation of
human cells with synthetic modifi ed mRNA. Cell Stem Cell 7:618–630
Wernig M, Meissner A, Cassady JP, Jaenisch R (2008) c-Myc is dispensable for direct reprogram-
ming of mouse fi broblasts. Cell Stem Cell 2:10–12
Xin M, Olson EN, Bassel-Duby R (2013) Mending broken hearts: cardiac development as a basis
for adult heart regeneration and repair. Nat Rev Mol Cell Biol 14:529–541
Xu C (2012) Turning cardiac fi broblasts into cardiomyocytes in vivo. Trends Mol Med
18:575–576
Xu C, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, Carpenter MK (2001) Feeder-free
growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19:971–974
Xu X-H, Zhong Z (2013) Disease modeling and drug screening for neurological diseases using
human induced pluripotent stem cells. Acta Pharmacol Sin 34:755–764
Yan X, Qin H, Qu C, Tuan RS, Shi S, Huang GT (2010) iPS cells reprogrammed from human
mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev 19:469–480
Yoshida T, Takayama K, Kondoh M, Sakurai F, Tani H, Sakamoto N, Matsuura Y, Mizuguchi H,
Yagi K (2011) Use of human hepatocyte-like cells derived from induced pluripotent stem cells
as a model for hepatocytes in hepatitis C virus infection. Biochem Biophys Res Commun
416:119–124
Yoshioka N, Gros E, Li HR, Kumar S, Deacon DC, Maron C, Muotri AR, Chi NC, Fu XD, Yu BD
et al (2013) Effi cient generation of human iPSCs by a synthetic self-replicative RNA. Cell
Stem Cell 13:246–254
Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA (2009) Human induced
pluripotent stem cells free of vector and transgene sequences. Science 324:797–801
Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir
GA, Ruotti V, Stewart R et al (2007) Induced pluripotent stem cell lines derived from human
somatic cells. Science 318:1917–1920
Yuan T, Liao W, Feng NH, Lou YL, Niu X, Zhang AJ, Wang Y, Deng ZF (2013) Human induced
pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, improve neuro-
logic function in a rat model of middle cerebral artery occlusion. Stem Cell Res Ther 4:73
Yu Y, Fisher JE, Lillegard JB, Rodysill B, Amiot B, Nyberg SL (2012) Cell therapies for liver
diseases. Liver Transpl 18:9–21
Yusa K, Rad R, Takeda J, Bradley A (2009) Generation of transgene-free induced pluripotent
mouse stem cells by the piggyBac transposon. Nat Methods 6:363–369
Zaida A, Liao W, Roemer EJ, Waaner M, Fink LM, Ward DC, Yupi M (2010) Reversal of hyper-
glycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic
β-like cells. Proc Natl Acad Sci USA 106:13426–13431
Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J et al (2009) Functional cardiomyocytes
derived from human induced pluripotent stem cells. Circ Res 104:30–41
Zhang N, An MC, Montoro D, Ellerby LM (2010) Characterization of human Huntington’s disease
cell model from induced pluripotent stem cells. PLoS Curr 2:Rrn1193
Zhang RR, Takebe T, Miyazaki L, Takayama M, Koike H, Kimura M, Enomura M, Zheng YW,
Sekine K, Taniguchi H (2014) Effi cient hepatic differentiation of human induced pluripotent
stem cells in a three-dimensional microscale culture. Methods Mol Biol 1210:131–141
Liu Z, Zhou J, Wang H, Zhao M, Wang C (2013) Current status of induced pluripotent stem cells
in cardiac tissue regeneration and engineering. Regen Med Res 1. http://www.regenmedres.
com/content/1/1/6
Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y et al (2009)
Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell
4:381–384
Zwi L, Caspi O, Arbel G, Huber I, Gepstein A et al (2009) Cardiomyocyte differentiation of human
induced pluripotent stem cells. Circulation 120:1513–1523


P.V. Pham et al.
Free download pdf